WallStreetZenWallStreetZen

NYSE: CHE
Chemed Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for CHE

Based on 1 analyst offering 12 month price targets for Chemed Corp

Min Forecast
$667.00+18.34%
Avg Forecast
$667.00+18.34%
Max Forecast
$667.00+18.34%

Should I buy or sell CHE stock?

Based on 1 analyst offering ratings for Chemed Corp.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model agrees with analyst consensus with a "Buy" rating. Learn More

Be the first to know when Wall Street analysts revise their CHE stock forecasts and price targets.

CHE stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-03-14

1 of 1

Forecast return on equity

Is CHE forecast to generate an efficient return?

Company
N/A
Industry
-75.03%
Market
61.99%

Forecast return on assets

Is CHE forecast to generate an efficient return on assets?

Company
N/A
Industry
8.81%

CHE earnings per share forecast

What is CHE's earnings per share in the next 2 years based on estimates from 2 analysts?

Avg 1 year Forecast
$23.53+17.06%
Avg 2 year Forecast
$25.87+28.68%
CHE's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

CHE revenue forecast

What is CHE's revenue in the next 3 years based on estimates from 1 analyst?

Avg 1 year Forecast
$2.6B+8.02%
Avg 2 year Forecast
$2.8B+15.56%
Avg 3 year Forecast
$3.0B+22.17%
CHE's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CHE earnings growth forecast

How is CHE forecast to perform vs Medical Care Facilities companies and vs the US market?

Company
13.44%
Industry
11.89%
Market
23.64%
CHE's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
CHE's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
CHE's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

CHE revenue growth forecast

How is CHE forecast to perform vs Medical Care Facilities companies and vs the US market?

Company
7.36%
Industry
6.03%
Market
10.68%
CHE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CHE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CHE vs Medical Care Facility Stocks

TickerPricePrice TargetUp/downsideConsensus
CHE$563.62$667.00+18.34%Buy
ENSG$119.93$166.14+38.53%Strong Buy
EHC$96.12$116.00+20.68%Strong Buy
UHS$157.05$222.36+41.59%Buy
THC$110.41$171.15+55.02%Strong Buy
View Top Medical Care Facility Stocks

Chemed Stock Forecast FAQ

Is Chemed Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NYSE: CHE) stock is to Buy CHE stock.

Out of 1 analyst, 0 (0%) are recommending CHE as a Strong Buy, 1 (100%) are recommending CHE as a Buy, 0 (0%) are recommending CHE as a Hold, 0 (0%) are recommending CHE as a Sell, and 0 (0%) are recommending CHE as a Strong Sell.

If you're new to stock investing, here's how to buy Chemed stock.

What is CHE's earnings growth forecast for 2025-2026?

(NYSE: CHE) Chemed's forecast annual earnings growth rate of 13.44% is forecast to beat the US Medical Care Facilities industry's average forecast earnings growth rate of 11.89%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 23.64%.

Chemed's earnings in 2025 is $301,999,000.On average, 2 Wall Street analysts forecast CHE's earnings for 2025 to be $344,401,433, with the lowest CHE earnings forecast at $344,401,433, and the highest CHE earnings forecast at $344,401,433.

In 2026, CHE is forecast to generate $378,578,116 in earnings, with the lowest earnings forecast at $369,869,283 and the highest earnings forecast at $387,286,950.

What is CHE's revenue growth forecast for 2025-2027?

(NYSE: CHE) Chemed's forecast annual revenue growth rate of 7.36% is forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 6.03%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.68%.

Chemed's revenue in 2025 is $2,431,287,000.On average, 1 Wall Street analysts forecast CHE's revenue for 2025 to be $38,441,669,381, with the lowest CHE revenue forecast at $38,441,669,381, and the highest CHE revenue forecast at $38,441,669,381. On average, 1 Wall Street analysts forecast CHE's revenue for 2026 to be $41,122,087,336, with the lowest CHE revenue forecast at $41,122,087,336, and the highest CHE revenue forecast at $41,122,087,336.

In 2027, CHE is forecast to generate $43,476,692,461 in revenue, with the lowest revenue forecast at $43,476,692,461 and the highest revenue forecast at $43,476,692,461.

What is CHE's forecast return on assets (ROA) for 2025-2027?

(NYSE: CHE) forecast ROA is N/A, which is lower than the forecast US Medical Care Facilities industry average of 8.81%.

What is CHE's Price Target?

According to 1 Wall Street analyst that have issued a 1 year CHE price target, the average CHE price target is $667.00, with the highest CHE stock price forecast at $667.00 and the lowest CHE stock price forecast at $667.00.

The Wall Street analyst predicted that Chemed's share price could reach $667.00 by Mar 14, 2026. The average Chemed stock price prediction forecasts a potential upside of 18.34% from the current CHE share price of $563.62.

What is CHE's Earnings Per Share (EPS) forecast for 2025-2026?

(NYSE: CHE) Chemed's current Earnings Per Share (EPS) is $20.10. On average, analysts forecast that CHE's EPS will be $23.53 for 2025, with the lowest EPS forecast at $23.53, and the highest EPS forecast at $23.53. In 2026, CHE's EPS is forecast to hit $25.87 (min: $25.27, max: $26.46).

What is CHE's forecast return on equity (ROE) for 2025-2027?

(NYSE: CHE) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.